GlassScriptPhysician profile
Leia Edenfield
NPI 1922462464
$1,625.55
in general payments reported to CMS, 2019-2025
22 companies · $482 in 2025
The $482 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $253 · 2023: $122 · 2024: $537 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $309.86 | 2024-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $213.16 | 2021-2025 | Gore Viabahn Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Boston Scientific Corporation | $165.00 | 2024-2025 | Varithena Administration Pack, General - Therapies |
| Medtronic, INC. | $161.38 | 2024-2025 | Endurant Iis |
| Cardiovascular Systems INC. | $148.13 | 2021 | |
| Philips North America LLC | $110.02 | 2022 | |
| Lemaitre Vascular, INC. | $71.26 | 2022-2024 | Artegraft Vascular Graft, Syntel Embolectomy Catheter (Spring Tip) |
| Organogenesis INC. | $69.58 | 2024-2025 | Via Matrix |
| Inari Medical, INC. | $54.43 | 2022 | |
| Surmodics, INC. | $48.52 | 2022 | |
| Solventum Corporation | $40.63 | 2025 | V.A.C. Veraflo, Prevena, V.A.C.Ulta |
| Cashflow Solutions, LLC | $33.87 | 2024-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Stryker Corporation | $31.72 | 2025 | Artix Mt |
| Acera Surgical, INC. | $23.94 | 2025 | Restrata Wound Matrix |
| Kerecis Limited | $22.98 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $21.66 | 2024 | Xarelto |
| Novo Nordisk INC | $19.27 | 2025 | Wegovy |
| Smith+Nephew, INC. | $18.54 | 2024 | Grafix Pl, Grafix, Stravix |
| Silk Road Medical, INC. | $18.09 | 2022 | |
| Argon Medical Devices, INC. | $15.29 | 2024 | Clot Management |
| Heron Therapeutics, INC. | $14.51 | 2023 | Zynrelef |
| Irhythm Technologies, INC. | $13.71 | 2023 | Zio Xt Patch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leia Edenfield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.